Recruiting NCT07449195
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Intalight Dream OCT, Heidelberg Spectralis OCT.
- Who it may be relevant to
- Registry conditions: Ocular Tumor. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Ocular Imaging for Monitoring of Ocular Tumor Disease
Overview
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Interventions
- Diagnostic test Intalight Dream OCT
This is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices. - Diagnostic test Heidelberg Spectralis OCT
This is the standard of care for optical imaging.
Primary outcome measures
- Image quality for participants [Time frame: Up to 1 year]
- Field of view for participants [Time frame: Up to 1 year]
Eligibility criteria
Inclusion criteria
- Age ≥18 years.
- At least 1 eye that has an intraocular or ocular surface tumor.
- The presence of a natural crystalline lens or intraocular lens.
- Pupils that can dilate up to at least 3 mm in the study eyes.
- The absence of opaque natural crystalline lenses or the presence of any ocular disease that prevents the view of the retina for imaging.
- Patients must be able to fixate on the imaging target.
- Patients must be able to sit still for a period of time (approximately 2 minutes).
Exclusion criteria
- Does not meet ALL of the above conditions
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
United States · 7 centers
- Memorial Sloan Kettering at Basking Ridge (Consent Only) — Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) — Middletown
- Memorial Sloan Kettering Bergen (Consent Only) — Montvale
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) — Commack
- Memorial Sloan Kettering Westchester (Consent Only) — Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites) — New York
- Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) — Uniondale
Identifiers
NCT: NCT07449195 · 25-314